Bone remolding in alveolar cleft site repaired by inorganic ceramic scaffolds loaded with BMP-2 via lyophilization

doi:10.19438/j.cjoms.2018.03.006

Abstract

Abstract: PURPOSE: To load BMP-2 on a novel inorganic ceramic scaffold material, OsteoBoneTM, through lyophilization, and explore its effect on bone formation after bone graft in vivo. METHODS: BMP-2 was loaded onto OsteoBoneTM scaffolds by coating it via lyophilization with trehalose added as stabalizer. The samples were incubated in PBS in vitro and the release rate was examined with BCA method and alkaline phosphatase (ALP) activity was detected. Eighteen SD rats were used as experimental animals. Critical size defects (CSD) of 4 mm×3 mm×3 mm were established on maxillary alveolar bone in SD rats. Scaffolds alone (group A), BMSC-scaffolds (group B)and BMP-2-scaffolds (group C) were used to be grafted into CSDs. Micro-CT and H-E staining were performed respectively 3,6 weeks post-surgery. SPSS 19.0 software package was used for statistical analysis. RESULTS: BMP-2 performed sustained release and maintained bioactivity for enhanced osteogenesis from lyophilized OsteoBoneTM scaffolds in vitro. Three weeks after surgery, H-E staining showed sparse braided bone, and there was no significant difference between the three groups; there was no significant difference in micro-CT analysis of bone volume/tissue volume (BV/TV) and trabecular thickness. Six weeks after surgery, H-E staining revealed abundant bone regeneration and osseous tissue was mature in group B and group C, and new bone formation trend was more apparent than in group A. Micro-CT analysis showed that BV/TV and trabecular thickness in group B and C was significantly greater than that in group A, and there was no significant difference between group B and group C. CONCLUSIONS: Loading BMP-2 on OsteoBoneTM scaffolds through lyophilization can significantly enhance the osteogenic capacity and achieve a similar effect to mesenchymal stem cells.

Key words: Tissue engineering bone, Alveolar cleft, Scaffold, BMP-2, Lyophilization

CLC Number:

R318.08

OUYANG Wan-lu, QIAN Yu-fen.. Bone remolding in alveolar cleft site repaired by inorganic ceramic scaffolds loaded with BMP-2 via lyophilization[J]. China Journal of Oral and Maxillofacial Surgery, 2018, 16(3): 222-226.

References

[1] 黄迪炎，陈海龙. 先天性唇腭裂治疗现状[J]. 实用医药杂志, 2003, 20(1): 68-70.
[2] Cho-Lee GY, García-Díez EM, Nunes RA, et al. Review of secondary alveolar cleft repair[J]. Ann Maxillofac Surg, 2013, 3(1): 46-50.
[3] Klijn RJ, van den Beucken JJ, Félix Lanao RP, et al. Three different strategies to obtain porous calcium phosphate cements: comparison of performance in a rat skull bone augmentation model [J]. Tissue Eng Part A, 2012, 18(11-12): 1171-1182.
[4] Middleton JC, Tipton AJ. Synthetic biodegradable polymers as orthopaedic devices [J]. Biomaterials, 2000, 21(23): 2335-2346.
[5] Yang S, Leong KF, Du Z, et al. The design of scaffolds for use in tissue engineering. Part Ⅰ. Traditional factors[J]. Tissue Eng, 2001, 7(6): 679-689.
[6] Ramakrishna S, Huang ZM, Kumar GV, et al. An introduction to biocomposites [M]. London: Imperial College Press, 2004: 36.
[7] E LL, Xu LL, Wu X, et al. The interactions between rat-adipose-derived stromal cells, recombinant human bone morphogenetic protein-2, and beta-tricalcium phosphate play an important role in bone tissue engineering[J]. Tissue Eng Part A, 2010, 16(9): 2927-2940.
[8] Sohier J, Daculsi G, Sourice S, et al. Porous beta tricalcium phosphate scaffolds used as a BMP-2 delivery system for bone tissue engineering [J]. J Biomed Mater Res A, 2010, 92(3): 1105-1114.
[9] Dohzono S, Imai Y, Nakamura H, et al. Successful spinal fusion by E. coli-derived BMP-2-adsorbed porous beta-TCP granules: a pilot study [J]. Clin Orthop Relat Res, 2009, 467(12): 3206-3212.
Ruhé PQ, Kroese-Deutman HC, Wolke JG, et al. Bone inductive properties of rhBMP-2 loaded porous calcium phosphate cement implants in cranial defects in rabbits [J]. Biomaterials, 2004, 25(11): 2123-2132.
[11] Luvizuto ER, Tangl S, Zanoni G, et al. The effect of BMP-2 on the osteoconductive properties of b-tricalcium phosphate in rat calvaria defects [J]. Biomaterials, 2011, 32(15): 3855-3861.
[12] Abarrategi A, Moreno-Vicente C, Ramos V, et al. Improvement of porous beta-TCP scaffolds with rhBMP-2 chitosan carrier film for bone tissue application [J]. Tissue Eng Part A,2008, 14(8): 1305-1319.
[13] Kim JW, Choi KH, Yun JH, et al. Bone formation of block and particulated biphasic calcium phosphate lyophilized with Escherichia coli-derived recombinant human bone morphogenetic protein 2 in rat calvarial defects [J]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2011, 112(3): 298-306.
[14] Abdelwahed W, Degobert G, Stainmesse S, et al. Freeze-drying of nanoparticles: formulation, process and storage considerations [J]. Adv Drug Deliv Rev, 2006, 58(15): 1688-1713.
[15] Griebenow K, Klibanov AM. Lyophilization-induced reversible changes in the secondary structure of proteins [J]. Proc Natl Acad Sci USA, 1995, 92(24): 10969-10976.
[16] Kasper JC, Schaffert D, Ogris M, et al. Development of a lyophilized plasmid/LPEI polyplex formulation with long-term stability-A step closer from promising technology to application [J]. J Control Release, 2011, 151(3): 246-255.
[17] Crowe JH, Carpenter JF, Crowe LM. The role of vitrification in anhydrobiosis [J]. Annu Rev Physiol, 1998, 60: 73-103.
[18] Lins RD, Pereira CS, Hunenberger PH. Trehalose-protein interaction in aqueous solution [J]. Proteins, 2004, 55(1): 177-186.
[19] 许悦, 陈振琦, 吴军, 等. 唇腭裂合并的单侧牙槽突裂大鼠模型的建立和稳定性研究 [J]. 上海交通大学学报(医学版), 2010, 30(9): 1111-1114.
[20] Habraken WJ, Boerman OC, Wolke JG, et al. In vitro growth factor release from injectable calcium phosphate cements containing gelatin microspheres [J]. J Biomed Mater Res A, 2009, 91(2): 614-622.
[21] Zhao J, Wang SY, Bao JQ, et al. Trehalose maintains bioactivity and promotes sustained release of BMP-2 from lyophilized CDHA scaffolds for enhanced osteogenesis in vitro and in vivo[J]. PLoS One, 2013, 8(1): e54645.